{"name":"Revolo Biotherapeutics","slug":"revolo-biotherapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxPU3RGMlFjcVVhSnVqOE1mbUlPNEtjOEU2V1hlNG05czhRZ3B1MkZRY0pTTHR5UEFqQTlJUnYyOUI1N0lodDl5N1V2S1NRQ0VmdkdVVTRHa1hpTmVPeTZ3eUVlV1lFREV1ZlFkMmpPZkZ5WWFCSDFQSU8wdER1ZXI2R25LWl80Q3ZGVm9OU24xd2I0VENzcVlUc0NlUHhZektWNldUR01ZNUdlYTNyNV9uLUJvUjc5dXBDMU1YTTlYeFNPVVFSRHRPLUgxQVRFZ2tSVWpTVlk1MGg4WTdDTzBnVXh0NV9ELW5sVFlBNG5IdzJsX0JvWkZoRkx6eThJRHRZQmUxMXZkYlFnMzZCX1p3X2x6U3hEUE90eERTZmwyV1Fhd2R2a2lMT184UVMzckdjNFVscENEMUFzbjdJaUgyUzBYcG5SRUk3V0w4dWhBTVhNWVU?oc=5","date":"2025-03-31","type":"regulatory","source":"Barchart.com","summary":"Rheumatoid Arthritis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Eli Lilly and Company, Philogen, I-Mab Biopharma Co. Ltd., Teijin Pharma -","headline":"Rheumatoid Arthritis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNNEgwYk02Zk9fTWpGNFByT2hrQUFQNUZIRmJKYm4xdkRyN0ZKckNNdk5zbVl3LV9JT1Zfem5xdjFrb253alM3SFI2OGthZENOdjUtbDlqcGJ2bHZjTUZlUTRMQm16Q3JTLWpCU2NkZV9lR0xWMHBvTHRiYXFlUWxqXzl0UEdxZnhvNmFWMDBNWFNUYUE0WTRHNnZyb1Q2Vlc1MnN6b2gtRFFvZ0xXeTJlUTdPaVVfYi04VEE?oc=5","date":"2025-03-10","type":"pipeline","source":"Stock Titan","summary":"Sernova Strengthens Diabetes Treatment Program With New R&D Chief - Stock Titan","headline":"Sernova Strengthens Diabetes Treatment Program With New R&D Chief","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxQSDRlcTFteFU3MEkzSnNQdTRXV2RZMTZ4RGk1ZTkyblltZTI1SDBBWjkzUnhNVmpTRkM1dDk0YnA3VWlJcVZnQ0pMMllPQ3RkOENmYkRxYldTcVpLQkh6ZEYxWUVUSlNXWVZsS3ZnazZRR3BzSllPNUFvM1hTRXdudjZacm91QkFGWkluWlZOdThaLUpXU2QwVS1JV0dzdFZndVJHVHdEMVJ6UkpxVUUwUFdXRENxLUtOTjdSMGdqWHdrNUkwVTBPdjlQazB5Z3hjTktIbXROcmt0Uk5XNThfVnRYVF9KQlY2bVhCUW5sRGdXUVdiTE9pdGFVRy0xVVliNjNMZFRfblpfVkdsSENjQ2RLdThzczQ?oc=5","date":"2025-03-04","type":"regulatory","source":"PR Newswire UK","summary":"Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance | DelveInsight - PR Newswire UK","headline":"Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNZHRHZnFkM1VjMzJveG54NFptWktkSW9KT0o3YWRVekNiaW9oNEZEM1haWVN2X1pib2ZkanVXeGloTEh6b0FJQk5YNktCT1hqSHprT3hBaDNhY2NDRUVBRlVrQ0Z5Mm45ZzZXZldTVmlZd25KbGhzOW02a3Zvb2hNejhha3Z0a1JTbTBjLTFfUUhXSHBYUDQyeUJfcWlqMXZiZkpxaE8xTkVpTXlUcmpCWk4xVEFIQzQ5enlyYlhkbFZqSEhtWjlsOA?oc=5","date":"2024-02-01","type":"regulatory","source":"Pharmacy Times","summary":"FDA Grants Orphan Drug Designation to ‘1104, First-In-Class Peptide for Eosinophilic Esophagitis - Pharmacy Times","headline":"FDA Grants Orphan Drug Designation to ‘1104, First-In-Class Peptide for Eosinophilic Esophagitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNa3dOZFZlNDRFam9Hd0tkOHRSWXFKNmJTSElFM01Bb1U5cHJoMFBiQS0zVWZSUG95aW1UR2NPZWVWbmdWOUtYa1dwNjAxZnNxWG5fR3dWd25WN0lpVEVwd0EyS2wzajg0Z0VuR3JLUUhBWG9wbjVmQTZFTV9TYTVCQUtZQ0ZYQnNDbmtCcll2VmNxamtMazBB?oc=5","date":"2023-04-19","type":"trial","source":"Fierce Biotech","summary":"Revolo drops dab of midphase data on would-be Dupixent rival - Fierce Biotech","headline":"Revolo drops dab of midphase data on would-be Dupixent rival","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPYXFwZ3BwV3JmVkVSakFUUnpaQVhFcFdseXlEY3RIUUdTMFVlaC1HR0RuQkhYSDYzQW1UcGU3R2pHOGZOUHhKUjdtQ3FPQzcwY1VVLWJPOUFjZUdkS3FVSExlRUJmdlNaZHJTNDB1bktlMHVwQ04xdnoxQTI5WWg2MnJ1UmZ5NGUxMnVqbS13dzdKdUZ5RlZNS2xoWVVRWmpPRTBpbUZLMF9SVVFXYWRJeXlZYkRqd2NBXzV0OE9wU1p4YXM1enVtbl9zRElqQjhpX0swUldGcy0xTlRXbU5lbG9HeXhreEg3elllYW1Hc2RSY3pTU3ZWWEVIYWE1NV90Uld3X05vbXQ?oc=5","date":"2022-07-26","type":"pipeline","source":"PR Newswire","summary":"New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsight - PR Newswire","headline":"New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQaUI4elU0RW1lRHEzcWZJY0VITUh0eXkzcmFZYmVvc0Z2UGtheDNZN3VCSVJjU1A0aGlJQy05V01XbDN6WnhWU3pGTVdtSmNuQ1h3aEJ2Ni01ZDV6enNkMjlveE1ZYm42TUY4QWhOLWRXdDZQN1hlbDB4YnhaVG5KM1J2aVlsZFd5WGhTZ2RMc3F6NTNtY25aZEVoTVU5dkJUZzRIc3R3M1pBS3U0VE5OV2hyS0h5ZDUxN1QzWlFYMHJod2MtV1VB?oc=5","date":"2022-02-28","type":"pipeline","source":"Hunt Scanlon Media","summary":"Panavance Therapeutics Inc. Appoints BarkerGilmore Senior Advisor Marla Persky to its Board of Directors - Hunt Scanlon Media","headline":"Panavance Therapeutics Inc. Appoints BarkerGilmore Senior Advisor Marla Persky to its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOSWZ2OElCenpVX1RvWlZkWm0zaWxhWUJPckJFWjNUbElVeTE1OWlIclQyVzZjSUl5bjY2Wl9UYmdOZXJSMG15a3FCNy1DQ3Utc3UxUzZYa2NFa0tkcUJrNUd5aERQYUJwTk5hckM1eklYc3N3RFZoNlh4bnZxRjJ4TC0zY0poZXg4SHN3Q25FWElfX0ZXT2dGT2h3NA?oc=5","date":"2021-08-26","type":"pipeline","source":"Bioprocess Online","summary":"Resetting The Immune System With Protein Therapeutics - Bioprocess Online","headline":"Resetting The Immune System With Protein Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQT01ZT0VlNEJSSm5wekxMNk5Ld05KZkxyOXV5bURRWmFJN0pzc3B1VllTSXBaRjNuamlUbmpCZ0J0TmhiM2s2QzI5cTY3b3pnd3VBdzF6UEVsMThkQnZEM3F3Ums3Zkx5anpscE9vNnRDTnhfYkcyc3FOMGFILWc4NzhwLVJuS3dOQXdYeWE1QXJhWnlndkE3OA?oc=5","date":"2021-05-06","type":"pipeline","source":"BioSpace","summary":"Get to Know Jonathan Rigby, Group CEO of Revolo Biotherapeutics - BioSpace","headline":"Get to Know Jonathan Rigby, Group CEO of Revolo Biotherapeutics","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}